Your browser doesn't support javascript.
Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report.
Rubinstein, Tal J.
  • Rubinstein TJ; Luxe Aesthetics, Oculofacial Plastic Surgery, Cary, North Carolina, U.S.A.
Ophthalmic Plast Reconstr Surg ; 37(6): e221-e223, 2021.
Article in English | MEDLINE | ID: covidwho-1440670
ABSTRACT
A 50-year-old woman with a history of controlled Graves' disease without clinical ophthalmopathy presents with 2 months of left more than right periorbital swelling and proptosis. Her eye symptoms and signs began 3 days following her second vaccination against the COVID-19 virus. Orbital imaging, elevated thyroid stimulating immunoglobulin, and negative systemic work up for other diseases were consistent with a diagnosis of active thyroid eye disease. The temporal relationship to her vaccination was likely consistent with autoimmune/inflammatory syndrome associated with adjuvants. Clinicians should remind patients of the symptoms and signs of thyroid eye disease and to seek appropriate medical and ophthalmic advice if they occur after the COVID-19 vaccine.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Graves Disease / Graves Ophthalmopathy / COVID-19 Type of study: Case report / Diagnostic study / Experimental Studies / Prognostic study Topics: Vaccines Limits: Female / Humans / Middle aged Language: English Journal: Ophthalmic Plast Reconstr Surg Journal subject: Ophthalmology Year: 2021 Document Type: Article Affiliation country: IOP.0000000000002059

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Graves Disease / Graves Ophthalmopathy / COVID-19 Type of study: Case report / Diagnostic study / Experimental Studies / Prognostic study Topics: Vaccines Limits: Female / Humans / Middle aged Language: English Journal: Ophthalmic Plast Reconstr Surg Journal subject: Ophthalmology Year: 2021 Document Type: Article Affiliation country: IOP.0000000000002059